Taiki Miyamoto Selected Research

flumioxazin

1/2022	Flumioxazin, a PPO inhibitor: A weight-of-evidence consideration of its mode of action as a developmental toxicant in the rat and its relevance to humans.
1/2021	Different effects of an N-phenylimide herbicide on heme biosynthesis between human and rat erythroid cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Taiki Miyamoto Research Topics

Disease

2	Anemia 01/2022 - 01/2021
2	Acute Erythroblastic Leukemia (Erythroleukemia) 01/2022 - 01/2021
2	Ventricular Heart Septal Defects (Ventricular Septal Defect) 01/2022 - 01/2021
1	Inflammation (Inflammations) 11/2007

Drug/Important Bio-Agent (IBA)

2	flumioxazinIBA 01/2022 - 01/2021
2	Heme (Haem)IBA 01/2022 - 01/2021
1	Protoporphyrinogen Oxidase (Protox)IBA 01/2021
1	ChlorophyllIBA 01/2021
1	HerbicidesIBA 01/2021
1	BradykininIBA 11/2007